NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1306829429 M.D.
Verify on CMS → Jeffrey Vorsanger, M.D.
Pulmonary Disease Physician in Brooklyn, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,323 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
8K
Medicare Part D claims · 611 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
85%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
90.9/100
▲ 8 pts above national avg 83.1 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Jeffrey Vorsanger, M.D. reported a CMS MIPS final score of 90.9/100 - above the 83.1 national average - and filed 8,441 Medicare Part D claims in 2023.
- 90.9/100
- MIPS score · +8 vs avg
- 8K
- Part D claims, 2023
- 85%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Jeffrey Vorsanger, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
91 Top 40% higher than 60% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Jeffrey Vorsanger, M.D. sits
This provider among pulmonary disease physician peers
Across the 2,676 pulmonary disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Jeffrey Vorsanger, M.D. writes more Part D claims than 98% of them and scores higher on MIPS quality than 63% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one pulmonary disease physician peer from a representative sample of 60; the gold marker is Jeffrey Vorsanger, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Jeffrey Vorsanger, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Jeffrey Vorsanger, M.D.?
High performer (top quartile)Primary specialty
Pulmonary Disease Physician
Medicare Part D claims
8,441 6× vs specialty avg
MIPS final score
90.9/100 7.8 pts vs avg
Specialty distribution in New York
How Pulmonary Disease Physician compares to other specialties among New York providers
Medicare quality performance, MIPS
Jeffrey Vorsanger, M.D.'s 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 90.9/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Pulmonary Disease Physician) - 90.9/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Jeffrey Vorsanger, M.D. appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding M.D. credentials at 2560 OCEAN AVE, Brooklyn, NY, 11229, with a listed phone of (718) 646-7878. NPI 1306829429 was issued on 11/22/2005.
Medicare Part D records for calendar year 2023 show 8,441 prescription claims written by this provider, covering 611 Medicare beneficiaries and totaling roughly $833K in drug spend, split 14% brand-name and 85% generic by claim count, with an opioid prescribing rate of 0.6%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 90.9/100 for the 2023 performance year (Quality 74.1), compared with the national average of 83.1.
Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,323 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1306829429 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 11/22/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
90.8564
Final Score
Avg: 83.1
74.1454
Quality
100
Promoting Interoperability
Reporting: Alternative Payment Model
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Jeffrey Vorsanger, M.D.. To verify Jeffrey Vorsanger, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Jeffrey Vorsanger, M.D. - brand share 14.0%
Pulmonary Disease Physician average
14% brand-name claims vs 85% generic, on 8,441 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
8,441
Total Claims
$833K
Total Drug Cost
611
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 19,488
- Total Day Supply
- 567,198
- Brand vs Generic
- 14% brand / 85% generic
- Brand Drug Cost
- $652K
- Generic Drug Cost
- $177K
- Opioid Claims
- 52 (0.6% rate)
- Antibiotic Claims
- 515
Patient Demographics
- Average Patient Age
- 78.3 years
- Avg HCC Risk Score
- 1.09
- Gender Split
- 65% female / 35% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Jeffrey Vorsanger, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
558 claims
- Amlodipine Besylate
Amlodipine Besylate
475 claims
- Losartan Potassium
Losartan Potassium
392 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
335 claims
- Simvastatin
Simvastatin
307 claims
- Levothyroxine Sodium
Levothyroxine Sodium
272 claims
- Metoprolol Succinate
Metoprolol Succinate
270 claims
- Synthroid
Synthroid
236 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 558 |
| Amlodipine Besylate | 475 |
| Losartan Potassium | 392 |
| Rosuvastatin Calcium | 335 |
| Simvastatin | 307 |
| Levothyroxine Sodium | 272 |
| Metoprolol Succinate | 270 |
| Synthroid Levothyroxine Sodium | 236 |
| Zolpidem Tartrate | 224 |
| Enalapril Maleate | 198 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Jeffrey Vorsanger, M.D. fits within the Pulmonary Disease Physician landscape nationally.
9,323
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider
Jeffrey Vorsanger, M.D.'s 8,441 claims are above the specialty average of 1,457.
Nearby Pulmonary Disease Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Vorsanger.
Dr. Antoine Tony Abed
MD
New York, NY
Dr. Michael Aboodi
M.D.
New York, NY
Dr. Jose Acevedo-Ramos
M.D.
Geneva, NY
Dr. Angelo Acquista
MD
New York, NY
Dr. Francis Adams
M.D.
New York, NY
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pulmonary Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore New York
Frequently Asked Questions
What is Jeffrey Vorsanger, M.D.'s specialty? ▼
Jeffrey Vorsanger, M.D. specializes in Pulmonary Disease Physician and practices in Brooklyn, New York. Credentials: M.D..
How much does Jeffrey Vorsanger, M.D. prescribe under Medicare Part D? ▼
In 2023, Jeffrey Vorsanger, M.D. wrote 8,441 Medicare Part D claims totaling $833K in drug costs for 611 beneficiaries.
What is Jeffrey Vorsanger, M.D.'s Medicare quality score? ▼
Jeffrey Vorsanger, M.D. has a CMS MIPS Final Score of 90.9/100 (Quality: 74.1). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Jeffrey Vorsanger, M.D. located? ▼
Jeffrey Vorsanger, M.D. is located at 2560 OCEAN AVE, Brooklyn, NY, 11229. Phone: (718) 646-7878.
What is Jeffrey Vorsanger, M.D.'s NPI number? ▼
Jeffrey Vorsanger, M.D.'s National Provider Identifier (NPI) is 1306829429, issued on 11/22/2005.
Does Jeffrey Vorsanger, M.D. prescribe more brand-name or generic drugs? ▼
Jeffrey Vorsanger, M.D.'s prescribing is 14% brand-name and 85% generic drugs by claim count, with $652K in brand drug costs.
Does Jeffrey Vorsanger, M.D. prescribe opioids? ▼
Yes, Jeffrey Vorsanger, M.D. had 52 opioid claims in 2023 with an opioid prescribing rate of 0.6%.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,323 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does Jeffrey Vorsanger, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Jeffrey Vorsanger, M.D.'s most frequently prescribed drugs include Atorvastatin Calcium, Amlodipine Besylate, Losartan Potassium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Jeffrey Vorsanger, M.D. accept Medicare? ▼
Jeffrey Vorsanger, M.D. appears in CMS Medicare data with 8,441 Part D claims and 611 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Jeffrey Vorsanger, M.D.'s credentials? ▼
Jeffrey Vorsanger, M.D.'s NPI is 1306829429 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.